The results presented in this work strengthen the potential therapeutic benefits of targeting γ-secretase in PCa and provide a rationale for stratifying patients who may be more responsive to this treatment owing to loss of PTEN that mediates activation of NOTCH signalling. The gene discussed is PTEN; the disease is posterior cortical atrophy.